Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes.

Sobngwi, E; Vexiau, P; Levy, V; Lepage, V; Mauvais-Jarvis, F; Leblanc, H; Mbanya, J C; Gautier, J F

Sobngwi, E; Vexiau, P; Levy, V; Lepage, V; Mauvais-Jarvis, F; Leblanc, H; Mbanya, J C; Gautier, J F.

Affiliation

Sobngwi E; Department of Diabetes and Metabolic Diseases, and Clinical Investigation Centre, Saint-Louis Hospital, Paris, France.

Diabet Med ; 19(10): 832-5, 2002 Oct.

Article in En | MEDLINE | ID: mdl-12358870

Subject(s)

C-Peptide/analysis; Diabetes Mellitus/blood; Insulin/therapeutic use; Acute Disease; Adult; Africa South of the Sahara; Autoantibodies/blood; Diabetes Mellitus/genetics; Diabetes Mellitus/immunology; Drug Administration Schedule; Follow-Up Studies; Genetic Predisposition to Disease; HLA-DR3 Antigen/analysis; HLA-DR4 Antigen/analysis; Humans; Insulin/blood; Insulin Resistance; Islets of Langerhans/immunology; Logistic Models; Middle Aged; Remission Induction; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: C-Peptide / Diabetes Mellitus / Insulin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Country/Region as subject: Africa Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2002 Document type: Article Affiliation country: France Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links